Tag : Biosimilar

Latest News

COVID-19 Impacts: Biosimilar Monoclonal Antibodies (mAbs) Market will Accelerate at a CAGR of over 30% through 2020-2024|Increase in Prevalence of Chronic Diseases to Boost Growth| Technavio

Newsemia
LONDON–(BUSINESS WIRE)– #BiosimilarMonoclonalAntibodiesmAbsMarket–The Global Biosimilar Monoclonal Antibodies (mAbs) Market will grow by USD 8.65 bn during 2020-2024 Source link...
Pharma / Biotech

A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers.

Newsemia
Related Articles A randomized phase I pharmacokinetic trial comparing the potential biosimilar adalimumab (CinnoRA®) with the reference product (Humira®) in healthy volunteers. Expert Opin Investig...
Latest News

Meiji Seika Pharma and Dong-A Socio Holdings Initiate Phase I Clinical Trial of DMB-3115, a Ustekinumab Biosimilar Candidate

Newsemia
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan, President and Representative Director: Daikichiro Kobayashi, “Meiji”) and Dong-A Socio Holdings Co., Ltd. (Headquarters: Seoul, Korea,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy